Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou

Chinese Medical Journal

Volumn 119, Issue 21, 2006, Pages 1794-1801

  Huang, Qin ^a   Wang, Ting Huai ^a   Lu, Wen Sheng ^b   Mu, Pan Wei ^a   Yang, Yan Fang ^a   Liang, Wei Wen ^a   Li, Cai Xia ^a   Lin, Gui Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Estrogen receptor alpha; Gene polymorphism; Pathogenesis; Postmenopausal women; Type 2 diabetes

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AGING; ARTICLE; CASE CONTROL STUDY; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; POSTPRANDIAL STATE; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 33751086418     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200611010-00006     Document Type: Article

References (35)

1. Geisler JG, Zawalich W, Zawalich K, Lakey JR, Stukenbrok H, Milici AJ, et al. Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes 2002; 51: 2158-2169.
2. Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, et al. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 2005; 88: C1317-1331.
3. Lundholm L, Moverare S, Steffensen KR, Nilsson M, Otsuki M, Ohlsson C, at al. Gene expression profiling identifies liver X receptor alpha as an estrogen-regulated gene in mouse adipose tissue. J Moll Endocrinol 2004; 32: 879-892.
4. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 1997; 40: 843-849.
5. Knopp RH, Zhu X. Multiple beneficial effects of estrogen on lipoprotein metabolism. J Clin Endocrinol Metab 1997; 82: 3952-3954.
6. Szoke E, Gerich JE. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Compr Ther 2005; 31: 106-112.
7. Speer G, Cseh K, Winkler G, Vargha P, Braun E, Takacs I, at al. Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 2001; 144: 385-389.
8. Di Croce L, Bruscalupi G, Trentalance A. Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment. Biochem Biophys Res Commun 1996; 224: 345-350.
9. Ibim SE, Randall R, Han P, Musey PI. Modulation of hepatic glucose-6-phosphate dehydrogenase activity in male and female rats by estrogen. Life Sci 1989; 45: 1559-1565.
10. Sandoval DA, Ertl AC, Richardson MA, Tate DB, Davis SN. Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes 2003; 52: 1749-1755.
11. Nadal A, Rovira JM, Laribi O, Leon-quinto T, Andreu E, Ripoll C, et al. Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor. FASEB J 1998; 12: 1341-1348.
12. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci USA 2004; 101: 2076-2081.
13. Hill SM, Fuqua SA, Chamness GC, Greene GL, McGuire WL. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res 1989; 49: 145-148.
14. Yaich L, Dupont WD, Cavener DR, Parl FF. Analysis of the Pvull restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res 1992; 52: 77-83.
15. Menasce LP, White GR, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993; 17: 263-265.
16. Long J, Liu P, Zhang Y, Shen H, Liu Y, Dvornyk V, at al. Interaction effects between estrogen receptor alpha gene, vitamin D receptor gene, age, and sex on bone mineral density in Chinese. J Hum Genet 2003; 48: 514-519.
17. Liu JM, Zhu HM, Zhu XY, Dai M, Jiang L, Xu MY, et al. Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women. Chin Med J 2003; 116: 364-367.
18. Matsushita H, Kurabayashi T, Tomita M, Tanaka K. Effects of vitamin D and estrogen receptor gene polymorphisms on the changes in lumbar bone mineral density with multiple pregnancies in Japanese women. Hum Reprod 2004; 19: 59-63.
19. Deng HW, Li J, Li JL, Johnson M, Gong G, Recker RR. Association of VDR and estrogen receptor genotypes with bone mass in postmenopausal Caucasian women: different conclusions with different analyses and the implications. Osteoporos Int 1999; 9: 499-507.
20. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA, at al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002; 105: 1879-1882.
21. Aquila S, Sisci D, Gentile M, Middea E, Catalano S, Carpino A, at al. Estrogen receptor (ER) alpha and ER beta are both expressed in human ejaculated spermatozoa: evidence of their direct interaction with phosphatidylinositol-3-OH kinase/Akt pathway. J Clin Endocrinol Metab 2004; 89: 1443-1451.
22. Ando' S, Panno ML, Salerno M, Sisci D, Mauro L, Lanzino M, at al. Role of IRS-1 signaling in insulin-induced modulation of estrogen receptors in breast cancer cells. Biochem Biophys Res Commun 1998; 253: 315-319.
23. Karl M, Potier M, Schulman IH, Rivera A, Werner H, Fomoni A, at al. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells. Endocrinology 2005; 146: 889-900.
24. Sottile V, Seuwen K, Kneissel M. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone). Calcif Tissue Int 2004; 75: 329-337.
25. Bourdoncle A, Labesse G, Margueron R, Castet A, Cavailles V, Royer CA. The nuclear receptor coactivator PGC-1alpha exhibits modes of interaction with the estrogen receptor distinct from those of SRC-1. J Mol Biol 2005; 347: 921-934.
26. Hentschke M, Susens U, Borgmeyer U. PGC-1 and PERC, coactivators of the estrogen receptor-related receptor gamma. Biochem Biophys Res Commiun 2002; 299: 872-879.
27. Wang X, Abdel-Rahman AA. Estrogen modulation of 6NOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am J Physiol Heart Circ Physiol 2002; 282: H2309-H2315.
28. Sale MM, Freedman BI, Langefeld CD, Williams AH, Hicks PJ, Colicigno CJ, at al. A genome-wide scan for type 2 diabetes in Africa n-American families reveals evidence for a locus on chromosome 6q. Diabetes 2004; 53: 830-837.
29. Xiang K, Wang Y, Zheng T, Jia W, Li J, Chen L, et al. Genome-wide search for type 2 diabetes/Impaired glucose homeostasis susceptibility genes in the Chinese (significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24). Diabetes 2004; 53: 228-234.
30. Paik SG, Michelis MA, Kim YT, Shin S. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens. Diabetes 1982; 31(8 Pt 1): 724-729.
31. Van Beek AP, Ruijter-Heijstek FC, Jansen H, Erkelens DW, de Bruin TW. Sex steroids and plasma lipoprotein levels in healthy women: The importance of androgens in the estrogen-deficient state. Metabolism 2004; 53: 187-192.
32. Arslanian SA, Heil BV, Becker DJ, Drash AL. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991; 72: 920-926.
33. Blum A, Cannon RO III. Selective estrogen receptor modulator effects on serum lipoproteins and vascular function in postmenopausal women and in hypercholesterolemic men. Ann N Y Acad Sci 2001; 949: 168-174.
34. Carr MC, Knopp RH, Brunzell JD, Wheeler BS, Zhu X, Lakshmanan M, et al. Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy. Diabetes Care 2005; 28:1555-1561.
35. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, et al. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991; 72: 934-944.